Amendment (g) Unblinded Extension Phase of Somatropin in Patients With Idiopathic Short Stature

NCT00191074 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

11

Enrollment

INDUSTRY

Sponsor class

Conditions

Growth Disorder

Interventions

DRUG: somatropin, rDNA origin, for injection

Sponsor

Eli Lilly and Company